Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 19, 2010Cancer

Midtreatment 18F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

Pier Luigi ZinzaniPier Luigi ZinzaniUniversité Claude Bernard Lyon 1LGLetizia GandolfiUniversity of BolognaABAlessandro BroccoliIstituto di Ematologia di Bologna

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zinzani et al. (2010) studied this question.

synapsesocial.com/papers/6a7201992163a0a01bc5e461https://doi.org/10.1002/cncr.25579
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nonparametric Estimation from Incomplete Observations1958 · 39,556 citations
  2. 2Poor Predictive Value of FDG-PET/CT Performed after 2 Cycles of R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLCL)2008 · 22 citations
  3. 3PET Scan Results of NCCTG N0489: Epratuzumab and Rituximab in Combination with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone Chemotherapy (ER-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma.2009 · 10 citations
  4. 4Phase II Study of Risk-Adapted Therapy of Newly Diagnosed, Aggressive Non-Hodgkin Lymphoma Based on Midtreatment FDG-PET Scanning2009 · 71 citations
  5. 5Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma2002 · 207 citations